Sime, W.; Jemaà , M.; Abassi, Y.; Lasorsa, V.A.; Bonne Køhler, J.; Hansson, K.; Bexell, D.; Michaelis, M.; Cinatl, J.; Strand, D.;
et al. Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma. Int. J. Mol. Sci. 2020, 21, 6577.
https://doi.org/10.3390/ijms21186577
AMA Style
Sime W, Jemaà M, Abassi Y, Lasorsa VA, Bonne Køhler J, Hansson K, Bexell D, Michaelis M, Cinatl J, Strand D,
et al. Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma. International Journal of Molecular Sciences. 2020; 21(18):6577.
https://doi.org/10.3390/ijms21186577
Chicago/Turabian Style
Sime, Wondossen, Mohamed Jemaà , Yasmin Abassi, Vito Alessandro Lasorsa, Julie Bonne Køhler, Karin Hansson, Daniel Bexell, Martin Michaelis, Jindrich Cinatl, Daniel Strand,
and et al. 2020. "Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma" International Journal of Molecular Sciences 21, no. 18: 6577.
https://doi.org/10.3390/ijms21186577
APA Style
Sime, W., Jemaà , M., Abassi, Y., Lasorsa, V. A., Bonne Køhler, J., Hansson, K., Bexell, D., Michaelis, M., Cinatl, J., Strand, D., Capasso, M., & Massoumi, R.
(2020). Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma. International Journal of Molecular Sciences, 21(18), 6577.
https://doi.org/10.3390/ijms21186577